Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling

被引:151
|
作者
Peltzer, Nieves [1 ]
Darding, Maurice [1 ]
Walczak, Henning [1 ]
机构
[1] UCL, UCL Canc Inst, Ctr Cell Death Canc & Inflammat CCCI, Mortimer St, London WC1E 6BT, England
基金
英国惠康基金;
关键词
NF-KAPPA-B; CAUSES EMBRYONIC LETHALITY; SEVERE LIVER DEGENERATION; APOPTOSIS PROTEIN CIAP2; CHAIN ASSEMBLY COMPLEX; SHARPIN-DEFICIENT MICE; CELL-DEATH; LINEAR UBIQUITIN; IN-VIVO; C-FLIP;
D O I
10.1016/j.tcb.2016.01.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The kinase RIPK1 is an essential signaling node in various innate immune signaling pathways being most extensively studied in the TNFR1 signaling pathway. TNF signaling can result in different biological outcomes including gene activation and cell death induction in the form of apoptosis or necroptosis. RIPK1 is believed to be crucial for regulating the balance between these opposing outcomes. It is therefore not surprising that RIPK1 is highly regulated, most notably by phosphorylation, ubiquitination, and their respective reversals. In this review, we discuss the biological functions of RIPK1 within the context of TNFR1 signaling. Finally, we discuss recent advances in the knowledge on three ubiquitin E3 ligases that exert regulatory functions on RIPK1 signaling: cIAP1, cIAP2, and LUBAC.
引用
收藏
页码:445 / 461
页数:17
相关论文
共 50 条
  • [21] Comparative effects of TNFR1 and TNFR2 on the early TNF signaling.
    Rim, C. Ha
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [22] IAPs: Guardians of RIPK1
    Darding, M.
    Meier, P.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (01): : 58 - 66
  • [23] The double life of RIPK1
    Jin, Lei
    Chen, Jiezhong
    Liu, Xiao Ying
    Jiang, Chen Chen
    Zhang, Xu Dong
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (01):
  • [24] Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
    Fischer, Roman
    Kontermann, Roland E.
    Maier, Olaf
    ANTIBODIES, 2015, 4 (01): : 48 - 70
  • [25] Another face of RIPK1
    Green, Douglas R.
    EMBO REPORTS, 2015, 16 (06) : 674 - 675
  • [26] IAPs: Guardians of RIPK1
    M Darding
    P Meier
    Cell Death & Differentiation, 2012, 19 : 58 - 66
  • [27] TNFR1 & ANKYLOSING SPONDYLITIS
    Karaderi, T.
    Pointon, J.
    Harvey, D.
    Appleton, L.
    Farrar, C.
    Brown, M.
    Wordsworth, B. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 611 - 611
  • [28] Cloaked in ubiquitin, a killer hides in plain sight: the molecular regulation of RIPK1
    Justus, Scott J.
    Ting, Adrian T.
    IMMUNOLOGICAL REVIEWS, 2015, 266 (01) : 145 - 160
  • [29] SIGNALING PATHWAYS OF MUTANT TUMOUR NECROSIS FACTOR RECEPTOR 1(TNFR1)
    Negm, Ola
    Todd, Ian
    Tighe, Paddy
    ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 786 - 786
  • [30] Zafirlukast Is a Promising Scaffold for Selectively Inhibiting TNFR1 Signaling
    Vunnam, Nagamani
    Yang, Mu
    Lo, Chih Hung
    Paulson, Carolyn
    Fiers, William D.
    Huber, Evan
    Been, MaryJane
    Ferguson, David M.
    Sachs, Jonathan N.
    ACS BIO & MED CHEM AU, 2023, 3 (03): : 270 - 282